Literature DB >> 21282059

Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site.

Serdar Durdagi1, Murat Şentürk, Deniz Ekinci, Halis Türker Balaydın, Süleyman Göksu, Ö İrfan Küfrevioğlu, Alessio Innocenti, Andrea Scozzafava, Claudiu T Supuran.   

Abstract

Carbonic anhydrases (CAs, EC 4.2.1.1) are inhibited by sulfonamides, inorganic anions, phenols, coumarins (acting as prodrugs) and polyamines. A novel class of CA inhibitors (CAIs), interacting with the CA isozymes I, II (cytosolic) and IX, XII (transmembrane, tumor-associated) in a different manner, is reported here. Kinetic measurements allowed us to identify hydroxy-/methoxy-substituted benzoic acids as well as di-/tri-methoxy benzenes as submicromolar-low micromolar inhibitors of the four CA isozymes. Molecular docking studies of a set of such inhibitors within CA I and II allowed us to understand the inhibition mechanism. This new class of inhibitors binds differently compared to all other classes of inhibitors known to date: they were found between the phenol-binding site and the coumarin-binding site, filling thus the middle of the enzyme cavity. They exploit different interactions with amino acid residues and water molecules from the CA active site compared to other classes of inhibitors, offering the possibility to design CAIs with an interesting inhibition profile compared to the clinically used sulfonamides/sulfamates.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21282059     DOI: 10.1016/j.bmc.2011.01.016

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors.

Authors:  David P Martin; Seth M Cohen
Journal:  Chem Commun (Camb)       Date:  2012-04-24       Impact factor: 6.222

2.  Carbonic anhydrase from Apis mellifera: purification and inhibition by pesticides.

Authors:  Ercan Soydan; Ahmet Güler; Selim Bıyık; Murat Şentürk; Claudiu T Supuran; Deniz Ekinci
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

3.  Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies.

Authors:  Ciro Milite; Giorgio Amendola; Alessio Nocentini; Silvia Bua; Alessandra Cipriano; Elisabetta Barresi; Alessandra Feoli; Ettore Novellino; Federico Da Settimo; Claudiu T Supuran; Sabrina Castellano; Sandro Cosconati; Sabrina Taliani
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

4.  4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies.

Authors:  Hossam Nada; Ahmed Elkamhawy; Magda H Abdellattif; Andrea Angeli; Chang Hoon Lee; Claudiu T Supuran; Kyeong Lee
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

5.  Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico Studies.

Authors:  Ahmed Elkamhawy; Jiyu Woo; Hossam Nada; Andrea Angeli; Tarek M Bedair; Claudiu T Supuran; Kyeong Lee
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

6.  The synthesis of axially disubstituted silicon phthalocyanines, their quaternized derivatives and first inhibitory effect on human cytosolic carbonic anhydrase isozymes hCA I and II.

Authors:  Tayfun Arslan; Zekeriya Biyiklioglu; Murat Şentürk
Journal:  RSC Adv       Date:  2018-03-13       Impact factor: 3.361

Review 7.  Bioactive Natural Product and Superacid Chemistry for Lead Compound Identification: A Case Study of Selective hCA III and L-Type Ca2+ Current Inhibitors for Hypotensive Agent Discovery.

Authors:  Hélène Carreyre; Grégoire Carré; Maurice Ouedraogo; Clarisse Vandebrouck; Jocelyn Bescond; Claudiu T Supuran; Sébastien Thibaudeau
Journal:  Molecules       Date:  2017-05-31       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.